Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAX576 in Crohn's Disease Perianal Fistulas
NCT01316601Phase 2Completed
- Sponsor
- Gerhard Rogler
- Start
- Jan 2011
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dectrekumab in Crohn's disease, perianal fistula, sponsored by Gerhard Rogler. Started Jan 2011; status: completed.
02
Drugs
dectrekumab
03
Conditions
Crohn's diseaseperianal fistula
Beyond the preview
Go deeper on NCT01316601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316601.